Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-814
Closed -$8.18K 3480
2024
Q3
$8.18K Hold
814
﹤0.01% 3276
2024
Q2
$12.7K Sell
814
-31
-4% -$519 ﹤0.01% 3125
2024
Q1
$18.5K Sell
845
-1,433
-63% -$31.8K ﹤0.01% 3098
2023
Q4
$44.1K Buy
2,278
+1,357
+147% +$24.8K ﹤0.01% 2947
2023
Q3
$17K Buy
921
+49
+6% +$882 ﹤0.01% 2849
2023
Q2
$16.1K Buy
872
+15
+2% +$355 ﹤0.01% 2791
2023
Q1
$25K Buy
+857
New +$22.8K ﹤0.01% 2712

Other funds holding OPTN

Mariner's OPTN Position: Q4 2024 in Review

Mariner sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 814 shares — an estimated $8.18K sold.

Mariner first reported a position in OPTN in Q1 2023 and held it in 7 quarters. The position peaked at $44.1K in Q4 2023. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • Mariner reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • Mariner sold 814 OptiNose shares in Q4 2024, an estimated $8.18K.
  • Mariner first reported a position in OptiNose in Q1 2023 and held it in 7 quarters.
  • Mariner's OptiNose position peaked at $44.1K in Q4 2023.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on Mariner's 13F filing for Q4 2024, filed 13 Feb 2025.